News

- Sartorius Stedim Biotech (SSB), a leading international supplier for the biopharmaceutical industries, acquired the Scottish company BioOutsource Ltd. The privately owned company based in Glasgow, UK, has been operating in the biotechnology market since 2007, and in the...

Cristal Therapeutics, a privately-held life sciences company developing novel nanotherapeutics against cancer and other diseases, by using its patented CriPec® platform announced today the appointment of Jeroen Tonnaer as new Chief Business Officer responsible for Cristal Therapeutics’ business development,...

GlaxoSmithKline (GSK) has obtained Japanese approval for its Encruse Ellipta (umeclidinium). The Japanese Ministry of Health, Labour and Welfare (MHLW) granted approval for the drug to provide relief from various symptoms due to airway obstruction with...

Aduro Biotech has received orphan drug designation from US Food and Drug Administration (FDA) for its immuno-oncology product candidate CRS-207 to treat mesothelioma. Mesothelioma is a form of cancer that affects the smooth layer of mesothelial...

Sanofi Pasteur has received approval from US Food and Drug Administration (FDA) for its Quadracel (Diphtheria and Tetanus Toxoids and Acellular Pertussis Absorbed and Inactivated Poliovirus; DTaP-IPV) vaccine. The FDA granted approval for the vaccine for...

India-based Sun Pharmaceutical Industries has completed the merger with Ranbaxy, as part of a $3.2bn deal. Sun has started integration of the acquired business that allows the firm to become the fifth largest specialty generic pharmaceutical...

AstraZeneca has established a five-year research collaboration with Harvard Stem Cell Institute (HSCI) to adapt a technique that creates human beta cells from stem cells. AstraZeneca will use the technique in its screens of compound library...